Your browser doesn't support javascript.
loading
Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection.
Fahrmann, Johannes F; Schmidt, C Max; Mao, Xiangying; Irajizad, Ehsan; Loftus, Maureen; Zhang, Jinming; Patel, Nikul; Vykoukal, Jody; Dennison, Jennifer B; Long, James P; Do, Kim-Anh; Zhang, Jianjun; Chabot, John A; Kluger, Michael D; Kastrinos, Fay; Brais, Lauren; Babic, Ana; Jajoo, Kunal; Lee, Linda S; Clancy, Thomas E; Ng, Kimmie; Bullock, Andrea; Genkinger, Jeanine; Yip-Schneider, Michele T; Maitra, Anirban; Wolpin, Brian M; Hanash, Samir.
Affiliation
  • Fahrmann JF; Department of Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, Houston, Texas.
  • Schmidt CM; Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana.
  • Mao X; Department of Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, Houston, Texas.
  • Irajizad E; Department of Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, Houston, Texas.
  • Loftus M; Dana-Farber Brigham and Women's Cancer Center, Division of Gastrointestinal Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Zhang J; Dana-Farber Brigham and Women's Cancer Center, Division of Gastrointestinal Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Patel N; Department of Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, Houston, Texas.
  • Vykoukal J; Department of Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, Houston, Texas.
  • Dennison JB; Department of Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, Houston, Texas.
  • Long JP; Department of Biostatistics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas.
  • Do KA; Department of Biostatistics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas.
  • Zhang J; Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana.
  • Chabot JA; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, Department of Epidemiology, Columbia Mailman School of Public Health, New York, New York.
  • Kluger MD; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, Department of Epidemiology, Columbia Mailman School of Public Health, New York, New York.
  • Kastrinos F; Division of Digestive and Liver Diseases, Columbia University Irving Medical Cancer and the Vagelos College of Physicians and Surgeons, New York, New York, Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas; Herbert Irving Comprehensive Cancer Center, Colum
  • Brais L; Dana-Farber Brigham and Women's Cancer Center, Division of Gastrointestinal Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Babic A; Dana-Farber Brigham and Women's Cancer Center, Division of Gastrointestinal Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Jajoo K; Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Lee LS; Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Clancy TE; Dana-Farber Brigham and Women's Cancer Center, Division of Surgical Oncology, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Ng K; Dana-Farber Brigham and Women's Cancer Center, Division of Gastrointestinal Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Bullock A; Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
  • Genkinger J; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, Department of Epidemiology, Columbia Mailman School of Public Health, New York, New York.
  • Yip-Schneider MT; Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana.
  • Maitra A; Division of Digestive and Liver Diseases, Columbia University Irving Medical Cancer and the Vagelos College of Physicians and Surgeons, New York, New York, Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas.
  • Wolpin BM; Dana-Farber Brigham and Women's Cancer Center, Division of Gastrointestinal Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Hanash S; Department of Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, Houston, Texas. Electronic address: shanash@mdanderson.org.
Gastroenterology ; 160(4): 1373-1383.e6, 2021 03.
Article in En | MEDLINE | ID: mdl-33333055

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Mass Screening / CA-19-9 Antigen / Early Detection of Cancer Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies / Screening_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Gastroenterology Year: 2021 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Mass Screening / CA-19-9 Antigen / Early Detection of Cancer Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies / Screening_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Gastroenterology Year: 2021 Document type: Article Country of publication: United States